An Adaptation, Extension and Pre-Testing of an Interactive Decision Aid for Men Diagnosed with Localized Prostate Cancer in Iceland: A Mixed-Method Study.
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Your vote was cast
Thank you for your feedback
Thank you for your feedback
AuthorsEiriksdottir, Valgerdur Kristin
Valdimarsdottir, Heiddis B
Taylor, Kathryn L
Schwartz, Marc D
Gudmundsson, Eirikur Orri
Fridriksson, Jon Orn
MetadataShow full item record
CitationEiriksdottir VK, Jonsdottir T, Valdimarsdottir HB, et al. An Adaptation, Extension and Pre-Testing of an Interactive Decision Aid for Men Diagnosed with Localized Prostate Cancer in Iceland: A Mixed-Method Study [published online ahead of print, 2021 Nov 18]. Behav Med. 2021;1-14. doi:10.1080/08964289.2021.2000926
AbstractIn this study an interactive decision aid (DA) for men diagnosed with localized prostate cancer was adapted, extended and pre-tested. The DA's prototype was based on a literature review and other empirically tested DAs. Semi-structured interviews with 12 men (age 65-80) diagnosed with localized prostate cancer were conducted to get feedback on content, usability, and the DA's layout. The interviews were analyzed using thematic analysis and themes were identified using deductive and inductive coding. Participants found the accessibility of the information and the explicit values clarification tool helpful. Four themes were identified: (1) usability and design, (2) content and knowledge, (3) deciding factors of decision-making, and (4) social support. Participants valued receiving extensive and realistic information on surgery/radiation therapy side effects and getting unbiased presentations of treatment options. Following the thematic analysis, the DA was revised and tested in a survey among 11 newly diagnosed prostate cancer patients (age 60-74). The participants valued the DA and found it helpful when making a treatment decision, and all reported that they would recommend it to others making a prostate cancer treatment decision. The DA is currently being tested in a randomized clinical trial (RCT). This is the first DA developed for prostate cancer patients in Iceland and if the results of the RCT show that it is more effective than standard care in assisting newly diagnosed patients with their treatment decision, the DA can be easily translated and adapted to cultures similar to Iceland such as the Nordic countries. Keywords: decision aid; explicit values clarification; localized prostate cancer; treatment options.
DescriptionTo access publisher's full text version of this article click on the hyperlink below
- Ask the parents: Testing the acceptability and usability of a hypospadias decision aid.
- Authors: Binion K, Miller A, Misseri R, Kaefer M, Longtin K, Carroll A, Wiehe SE, Chan KH
- Issue date: 2022 Jan 16
- An Autonomy-Supportive Online Decision Aid to Assist Smokers in Choosing Evidence-Based Cessation Assistance: Development Process and Protocol of a Randomized Controlled Trial.
- Authors: Gültzow T, Smit ES, Hudales R, Knapen V, Rademakers J, Dirksen CD, Hoving C
- Issue date: 2020 Dec 15
- Developing a Decision Aid to Facilitate Informed Decision Making About Invasive Mechanical Ventilation and Lung Transplantation Among Adults With Cystic Fibrosis: Usability Testing.
- Authors: Dauber-Decker KL, Basile M, King D, Polo J, Calise K, Khan S, Solomon J, Dunne D, Hajizadeh N
- Issue date: 2021 Apr 14
- Developing a decision aid to support informed choices for newly diagnosed patients with localized prostate cancer.
- Authors: Chabrera C, Font A, Caro M, Areal J, Zabalegui A
- Issue date: 2015 Jan-Feb
- Randomized controlled trial on the effect of an online decision aid for young female cancer patients regarding fertility preservation.
- Authors: Ehrbar V, Urech C, Rochlitz C, Zanetti Dällenbach R, Moffat R, Stiller R, Germeyer A, Nawroth F, Dangel A, Findeklee S, Tschudin S
- Issue date: 2019 Sep 29